SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-23-011914
Filing Date
2023-05-01
Accepted
2023-05-01 16:33:48
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A wint20221231_10ka.htm   iXBRL 10-K/A 467505
2 EXHIBIT 31.3 ex_510707.htm EX-31.3 4401
3 EXHIBIT 31.4 ex_510702.htm EX-31.4 4476
4 EXHIBIT 32.2 ex_510697.htm EX-32.2 6220
  Complete submission text file 0001437749-23-011914.txt   740044

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20221231.xsd EX-101.SCH 3600
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20221231_def.xml EX-101.DEF 17162
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20221231_lab.xml EX-101.LAB 23277
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20221231_pre.xml EX-101.PRE 18143
10 EXTRACTED XBRL INSTANCE DOCUMENT wint20221231_10ka_htm.xml XML 6563
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39290 | Film No.: 23874282
SIC: 2836 Biological Products, (No Diagnostic Substances)